(Total Views: 380)
Posted On: 08/04/2019 8:49:30 AM
Post# of 150728
Re: ClosetInvestor #5751
A few drugs approved from Phase 2 -
Kyprolis - 10 months after BLA submission, accelerated approval, no priority review
crizotinib - 7 months after BLA submission. accelerated approval, priority review
atezolizumab - 6 months from BLA submission, accelerated approval, priority review
There have been over 30 cancer drugs approved based on Phase 2 data.
Kyprolis - 10 months after BLA submission, accelerated approval, no priority review
crizotinib - 7 months after BLA submission. accelerated approval, priority review
atezolizumab - 6 months from BLA submission, accelerated approval, priority review
There have been over 30 cancer drugs approved based on Phase 2 data.
(1)
(0)Scroll down for more posts ▼
